Shopping Cart
Remove All
Your shopping cart is currently empty
Drozitumab
😃Good
Catalog No. T76802Cas No. 912628-39-8
Alias rhuMAb-DR 5, RG7425, RG 7425, PRO95780, PRO 95780, Anti-Human DR5 Recombinant Antibody
Drozitumab (PRO 95780) is a fully humanized antibody targeting the death receptor DR5 that shows anti-tumor activity against rhabdomyosarcoma, binds to the death receptor DR5 and induces apoptosis, and can be used in the study of triple-negative breast cancer.
Drozitumab
Drozitumab
😃Good
Catalog No. T76802Alias rhuMAb-DR 5, RG7425, RG 7425, PRO95780, PRO 95780, Anti-Human DR5 Recombinant AntibodyCas No. 912628-39-8
Drozitumab (PRO 95780) is a fully humanized antibody targeting the death receptor DR5 that shows anti-tumor activity against rhabdomyosarcoma, binds to the death receptor DR5 and induces apoptosis, and can be used in the study of triple-negative breast cancer.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $197 | In Stock | In Stock | |
| 5 mg | $596 | In Stock | In Stock | |
| 10 mg | $959 | - | In Stock | |
| 25 mg | $1,420 | - | In Stock | |
| 50 mg | $1,920 | - | In Stock |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Batch Information
Select Batch
Purity:99.2% (SDS-PAGE); 98.9% (SEC-HPLC)
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Drozitumab (PRO 95780) is a fully humanized antibody targeting the death receptor DR5 that shows anti-tumor activity against rhabdomyosarcoma, binds to the death receptor DR5 and induces apoptosis, and can be used in the study of triple-negative breast cancer. |
| In vitro | Drozitumab is able to target and remove cancer stem cells (CSCs), thereby stopping tumor growth and potentially shrinking or even regressing pancreatic tumors. [3] Drozitumab caused apoptosis in mesenchymal TNBC cell lines, but did not show the same effect in other subtypes of breast cancer cell lines. [1] |
| Synonyms | rhuMAb-DR 5, RG7425, RG 7425, PRO95780, PRO 95780, Anti-Human DR5 Recombinant Antibody |
| Reactivity | Human |
| Application | Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Gene ID | |
| Uniprot ID | |
| Target | TNFRSF10B/TRAILR2/CD262 |
| Molecular Weight | 143.09 kDa |
| Cas No. | 912628-39-8 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG1 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Drozitumab | purchase Drozitumab | Drozitumab cost | order Drozitumab | Drozitumab in vitro | Drozitumab molecular weight
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.